| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2013 | Quantitative serum levels of hepatitis B surface antigen improve predictability of spontaneous eradication of hepatitis B virus in chronic hepatitis B patients | Liu, J; Lee, MH; Batrla-Utermann, R; Jen, CL; Iloeje, UH; Lu, SN; Wang, LY; You, SL; Hsiao, KC; Yang, HI; Chen, CJ; REVEAL-HBV Study Group | J Hepatol | | | |
| 2023 | Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities | Lin, HC; Liu, J; Pan, MH; Lee, MH; Batrla-Utermann, R; Lu, SN; Jeng, WJ; Yang, HI ; Chen, CJ | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 14(8), e00586 | | | |
| 2016 | Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis | Chien, J; Liu, J; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Journal of gastroenterology and hepatology 31(12), 1971-1977 | | | |
| 2017 | Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance | Huang, CF; Yeh, ML; Huang, CI; Lin, YJ; Tsai, PC; Lin, ZY; Chan, SY; Chen, SC; Yang, HI; Huang, JF; Lu, SN; Dai, CY; Jen, CL; Yuan, Y; L'Italien, G; Wang, LY; Lee, MH; Yu, ML; Chuang, WL; Chen, CJ | Oncotarget 8(27), 43925-43933 | | | |
| 2009 | Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study | Iloeje, UH; Yang, HI; Jen, CL; Su, J; Wang, LY; You, SL; Lu, SN; Chen, CJ | Liver Int 30:423-429 | | | |
| 2016 | Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression. | Liu, J; Yang, HI ; Lee, MH; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; You, SL; Chen, CJ | HEPATOLOGY 64(2), 381-389 | | | |
| 2017 | Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients | Liu, J; Hu, HH; Lee, MH; Korenaga, M; Jen, CL; Batrla-Utermann, R; Lu, SN; Wang, LY; Mizokami, M; Chen, CJ ; Yang, HI | Scientific reports 7, 14352 | | | |
| 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | | | |
| 2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 | | | |
| 2016 | The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. | Hu, HH; Liu, J; Lin, YL; Luo, WS; Chu, YJ; Chang, CL; Jen, CL; Lee, MH; Lu, SN; Wang, LY; You, SL; Yang, HI ; Chen, CJ | Gut 65, 1514-1521 | | | |
